Fuentes, Jonathan B.
HRN: 24-31-73 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/02/2024
CO-AMOXICLAV 625MG (TAB)
01/02/2024
01/09/2024
PO
625mg
TID
URTI
Waiting Final Action